Yes, variants in the GLP1R gene (e.g., rs6923761) have been associated with differences in weight loss response to GLP-1 medications in clinical studies
Disclaimer While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content
Conclusions Few conclusive results are available from clinical trials and from the literature (Fig
Start your intake Why GLP-1 Medications May Affect Energy Levels GLP-1 receptor agonists work primarily in the gastrointestinal system and brain to regulate appetite and blood sugar
Moreover, a comprehensive summary of the activation strategies of the GSH system is presented, where we mainly identify several promising herbal monomers, which may provide valuable guidelines for the exploration of new therapeutic approaches